Plain-English translation of NCT06756438 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a study testing a dermocosmetic emollient product (a special moisturizer) designed to help children with atopic dermatitis—a chronic skin condition that causes itching, dryness, and recurring flare-ups. Half of the children in the study will receive the new product while the other half receive a placebo (a product with no active ingredients), and researchers will measure whether the new treatment reduces how often flare-ups happen and how severe they are. All children will continue using their regular prescribed steroid creams as needed.
Atopic dermatitis is a long-lasting inflammatory skin disease that significantly impacts children's quality of life and sleep. Researchers want to see if this new moisturizing product, used alongside standard steroid treatments, can help reduce the number and severity of flare-ups and improve overall skin health.
You likely qualify if…
You likely don't qualify if…
Your child will be randomly assigned to receive either the study product or a placebo, and you'll apply it to your child's face and body as directed while continuing any prescribed steroid creams. You'll attend study visits where a dermatologist will measure your child's skin condition using a standardized scoring system, track flare-ups and symptoms like itching and dryness, and assess how well your child's skin tolerates the product. The study will also ask about your child's quality of life and sleep to see if the treatment helps beyond just skin symptoms.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Poland